SCHEMBL5219939

SCHEMBL5219939

CCNc1cc(C(=O)OC)c(F)c(N2CCCCS2(O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 13/20 0.43
BACE2 Q9Y5Z0 11/20 0.43
CTSD P07339 10/20 0.43
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 3/20 0.34
ALOX15 P16050 3/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 1/20 0.32
RAB9A P51151 2/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
AVPR2 P30518 1/20 0.31
HTT P42858 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5221778 0.97 BACE1 (0.41) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5219943 0.89 BACE1 (0.53) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5220629 0.89 BACE1 (0.43) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5221780 0.86 CTSD (0.34) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5221774 0.86 BACE1 (0.49) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5223182 0.85 BACE1 (0.40) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5223868 0.85 CTSD (0.34) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5223226 0.82 KDM4E (0.38) BACE1BACE2CTSDCYP3A4CYP2C19
SCHEMBL5219078 0.79 PTGS2 (0.33) ALDH1A1HSD17B10RAB9AKDM4ENPC1
SCHEMBL5219097 0.79 PTGS2 (0.33) ALDH1A1HSD17B10RAB9AKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed